ARTICLE | Company News
to-BBB, GlaxoSmithKline deal
March 8, 2010 8:00 AM UTC
GlaxoSmithKline received a non-exclusive license to evaluate to-BBB's G-Technology drug delivery technology to deliver therapeutics for undisclosed indications. The technology uses glutathione-coated ...